Atossa Therapeutics (ATOS) Inventory (2014 - 2015)
Atossa Therapeutics (ATOS) posted quarterly Inventory of $170860.0 for Q3 2015, up 272.51% year-over-year from $45867.0 in Q3 2014, and up 68.6% quarter-over-quarter from $101339.0 in Q2 2015.
Atossa Therapeutics (ATOS) Inventory (2014 - 2015) Analysis & Trends
Atossa Therapeutics (ATOS) has reported Inventory for 2 consecutive years, with $170860.0 the latest figure, recorded in Q3 2015.
- In Q3 2015, Inventory rose 272.51% year-over-year to $170860.0; the TTM figure through Sep 2015 stood at $170860.0 (up 272.51% YoY), while the FY2014 annual figure was $9276.0, changed N/A from the prior year.
- Inventory climbed to $170860.0 in Q3 2015 per ATOS's latest filing, from $101339.0 in the prior quarter.
- Across five years, Inventory topped out at $170860.0 in Q3 2015 and bottomed at $1910.0 in Q2 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 280.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 732.60 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 97.11 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 128.86 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 142.38 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Atossa Therapeutics | 22.63 Mn | 22.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 170,860.00 |
| Jun 30, 2015 | 101,339.00 |
| Mar 31, 2015 | 94,628.00 |
| Dec 31, 2014 | 9,276.00 |
| Sep 30, 2014 | 45,867.00 |
| Jun 30, 2014 | 1,910.00 |